Waters Corporation $WAT Shares Sold by Peak Financial Advisors LLC

Key Points

• Peak Financial Advisors LLC reduced its stake in Waters Corporation by 14.6%, now holding 7,079 shares valued at approximately $2.47 million.
• Waters Corporation reported earnings of $2.95 per share for the last quarter, exceeding analyst estimates of $2.93, with revenues of $771.33 million.
• Analysts have set a range of price targets for Waters, with Scotiabank issuing a target of $465.00 and an overall average target of $378.73 among the 15 analysts covering the stock.

Peak Financial Advisors LLC lessened its holdings in shares of Waters Corporation (NYSE:WAT - Free Report) by 14.6% in the second quarter, according to its most recent filing with the SEC. The firm owned 7,079 shares of the medical instruments supplier's stock after selling 1,213 shares during the quarter. Waters comprises approximately 1.3% of Peak Financial Advisors LLC's holdings, making the stock its 26th largest position. Peak Financial Advisors LLC's holdings in Waters were worth $2,471,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Olde Wealth Management LLC acquired a new position in Waters during the 1st quarter worth $25,000. Zions Bancorporation National Association UT acquired a new position in Waters during the 1st quarter worth $28,000. IFP Advisors Inc boosted its position in Waters by 118.9% during the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after acquiring an additional 44 shares during the period. Whipplewood Advisors LLC boosted its position in Waters by 5,200.0% during the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock worth $39,000 after acquiring an additional 104 shares during the period. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in shares of Waters in the first quarter valued at $41,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Analysts Set New Price Targets

WAT has been the subject of several research analyst reports. UBS Group restated a "neutral" rating on shares of Waters in a report on Tuesday, July 15th. Jefferies Financial Group set a $385.00 price objective on Waters and gave the company a "buy" rating in a report on Monday, August 4th. Wells Fargo & Company cut their price objective on Waters from $330.00 to $315.00 and set an "equal weight" rating for the company in a report on Tuesday, August 5th. Scotiabank restated a "sector outperform" rating and issued a $465.00 price objective on shares of Waters in a report on Friday, July 11th. Finally, Bank of America upped their price objective on Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, Waters currently has an average rating of "Hold" and an average price target of $378.73.

Waters Stock Down 2.3%

Shares of Waters stock opened at $295.40 on Friday. The stock's fifty day moving average is $299.65 and its 200-day moving average is $333.02. The firm has a market capitalization of $17.58 billion, a PE ratio of 26.64, a price-to-earnings-growth ratio of 2.82 and a beta of 1.07. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56.

Waters (NYSE:WAT - Get Free Report) last announced its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.93 by $0.02. The company had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%.Waters's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.63 earnings per share. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Equities analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.